Facebook Tracking Image

National Comprehensive Cancer Network

About NCCN

NCCN Global Academy Shines a Spotlight on Collaborative Efforts to Improve Access to Care

On Thursday, 18 October 2018, the National Comprehensive Cancer Network® (NCCN®) hosted the NCCN Global Academy for Excellence & Leadership in Oncology™: School of Pharmaceutical & Biotech Business in Munich, Germany. This event marks the first NCCN Academy event to take place outside of the United States.

Co-moderated by Wui-Jin Koh, MD, Senior Vice President, Chief Medical Officer, NCCN, and C. Lyn Fitzgerald, MJ, Senior Vice President, U.S. & Global Development, NCCN, the program featured two expert panels, the first of which was moderated by Dr. Koh and titled, Regional Adaptations - Meet NCCN Guidelines® Panel and Collaborative International Experts. The panelists in this module have all worked on the NCCN Guideline Adaptations or the NCCN Harmonized Guidelines™ and were asked to elaborate on the process of adapting the NCCN Guidelines. The panelists included:

  • Al B. Benson III, MD, FACP, FASCO / Chair, Professor of Medicine, Associate Director for Cooperative Groups, Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Chair, NCCN Guidelines for Colon/Rectal/Anal and Hepatobiliary Cancers Panels; Member, NCCN Guidelines for Neuroendocrine and Adrenal Tumors and Pancreatic Adenocarcinoma; Board Member, National Comprehensive Cancer Network; Board Member, NCCN Foundation
  • Abdul Rahman Jazieh, MD, MPH, Chairman, Department of Oncology, King Abdulaziz Medical City in Riyadh, Saudi Arabia; Director of the Coordinating Center, MENA; Collaborative International Expert for the NCCN Guideline for Non-Small Cell Lung Cancer: Middle East & North Africa (MENA) Editions
  • Gilian Wharfe, MD, Overall Clinical Chair 2018, Haematologist/Oncologist, Head if the Department of Pathology, The University of the West Indies, MONA, Jamaica; Collaborative International Expert for the NCCN Harmonized Guidelines™ for the Caribbean: Colon Cancer

The second module, titled Harmonizing Cancer Care for Patients with Resource Constraints, focused on opportunities and best practices for collaboration across stakeholders to help patients in areas of limited resources. Ms. Fitzgerald acted as moderator for the following panelists:

  • Al B. Benson III, MD, FACP, FASCO / Chair, Professor of Medicine, Associate Director for Cooperative Groups, Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Chair, NCCN Guidelines for Colon/Rectal/Anal and Hepatobiliary Cancers Panels; Member, NCCN Guidelines for Neuroendocrine and Adrenal Tumors and Pancreatic Adenocarcinoma; Board Member, National Comprehensive Cancer Network; Board Member, NCCN Foundation
  • Ambassador Sally G. Cowal, MA, Board Member of the Union of International Cancer Control (UICC); Senior Vice President, Global Cancer Control, American Cancer Society
  • Patricia Doykos, PhD, Director, Bristol-Myers Squibb Foundation
  • Wui-Jin Koh, MD, Senior Vice President/Chief Medical Officer, National Comprehensive Cancer Network
  • Gilian Wharfe, MD, Overall Clinical Chair 2018, Haematologist/Oncologist, Head if the Department of Pathology, The University of the West Indies, MONA, Jamaica; Collaborative International Expert for the NCCN Harmonized Guidelines™ for the Caribbean: Colon Cancer

Please contact Caitlin Donnelly for a detailed summary of this event.

 

About NCCN Global Academy

Be sure to look out for information on the 2019 NCCN Global Academy Program coming in the fall of 2019, in Barcelona, Spain!

Pharmaceutical and biotechnology professionals will have the rare opportunity to view the global oncology space, its future, and its current operational issues from the provider, payer, and patient advocate perspective. Participants improve their working knowledge of key global business, policy, informational, and operational issues in oncology and gather valuable insights material to developing effective strategies for navigating the various constituencies in consideration of worldwide cancer care issues. Through this interactive program, pharmaceutical and biotech professionals learn from key stakeholders what they view to be the most pressing issues in the global oncology environment and how to apply this knowledge to create mutually successful working relationships.

Professionals from marketing, sales, advocacy, medical affairs, clinical research, international programs, policy and government affairs, and other business areas are better able to serve their customers with improved knowledge of real-world oncology issues after completion of this program.